{"id":"W4409821253","doi":"10.1158/1538-7445.am2025-lb432","title":"Abstract LB432: Clinical-stage anticancer agent BOLD-100 demonstrates protective effects against oxaliplatin-induced peripheral neuropathy in an in-vivo rat model","year":2025,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"Oxaliplatin; In vivo; Peripheral neuropathy; Medicine; Pharmacology; Peripheral; Stage (stratigraphy); Cancer; Oncology; Internal medicine; Biology; Endocrinology; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003015642,0.0008317632,0.0005534869,0.0004336608,0.0002309471,0.0002565809,0.0004270287,0.0005906932,0.00416224],"category_scores_gemma":[0.0001331009,0.0002250828,0.0004789332,0.0003764848,0.0002679783,0.0004596872,0.0001618367,0.002253869,0.0008092078],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003415225,"about_ca_system_score_gemma":0.0006180144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002044661,"about_ca_topic_score_gemma":0.003203153,"domain_scores_codex":[0.999855,0.00002412915,0.00001145624,0.00002810978,0.0000306045,0.00005063385],"domain_scores_gemma":[0.999853,0.00001257027,0.00003426597,0.00001485604,0.00002224527,0.00006299855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005646937,0.003422237,0.0003291177,0.0003887057,0.0000539076,0.0001788096,0.00004121517,0.0004376642,0.9806137,0.0001856641,0.001322351,0.007379733],"study_design_scores_gemma":[0.001304321,0.04034843,0.007664867,0.00008164076,0.0002171288,0.0005572785,0.0001324879,0.003074551,0.9398499,0.0002192094,0.006514124,0.00003600581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850301,0.003617449,0.00341271,0.0004968844,0.0002426056,0.0002086217,0.002206502,0.0003797594,0.004405278],"genre_scores_gemma":[0.9807153,0.003827897,0.00334089,0.0003278957,0.00004400576,0.0003106249,0.003139346,0.00004452627,0.008249586],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00416224,"threshold_uncertainty_score":0.01392412,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1586708767037316,"score_gpt":0.5111299242472217,"score_spread":0.3524590475434901,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}